{
  "id": "4ff35a704c27ecc6",
  "title": "Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine ( CT1812 ) in Dementia with Lewy Bodies",
  "description": "20260127T131500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/cognition-therapeutics-completes-type-c-meeting-with-fda-for-zervimesine-ct1812-in-dementia-with-lewy-bodies/2265954",
  "published_at": "20260127T131500Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/cognition-therapeutics-completes-type-c-meeting-with-fda-for-zervimesine-ct1812-in-dementia-with-lewy-bodies/2265954",
    "url_mobile": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/cognition-therapeutics-completes-type-c-meeting-with-fda-for-zervimesine-ct1812-in-dementia-with-lewy-bodies/2265954/amp",
    "title": "Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine ( CT1812 ) in Dementia with Lewy Bodies",
    "seendate": "20260127T131500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/27/914153.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}